Prognostic significance of high-risk human papillomavirus and p16INK4A in patients with esophageal squamous cell carcinoma

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 10, 2014, Pages 3430-3438

  Cao, Fangli ^a,b   Zhang, Weihong ^b   Zhang, Fang ^c   Han, Hui ^b   Xu, Junlong ^b   Cheng, Yufeng ^a  

^a SHANDONG UNIVERSITY   (China)

^b LIAOCHENG PEOPLE'S HOSPITAL   (China)

^c First Hospital of Zibo   (China)

Author keywords

Esophageal cancer; Human papillomavirus; P16INK4A; Prognosis; Squamous cell carcinoma

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; COHENS KAPPA TEST; CONTROLLED STUDY; DISEASE CLASSIFICATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS RESECTION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; FOOLOW UP; HUMAN; HUMAN TISSUE; IMAGING; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; OVERALL SURVIVAL; PHYSICAL EXAMINATION; PROGRESSION FREE SURVIVAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; SURVIVAL RATE; THORACOTOMY; WART VIRUS;

EID: 84910065334     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey SM, Dong ZW, Mark SD, Qiao YL and Taylor PR. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 2005; 113: 456-463.
3. Mao WM, Zheng WH and Ling ZQ. Epidemiologic risk factors for esophageal cancer development. Asian Pac J Cancer Prev 2011; 12: 2461-2466.
4. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
5. Ries L, Melbert D, Krapcho M, Stinchcomb D, Howlader N, Horner M, Mariotto A, Miller B, Feuer E and Altekruse S. SEER Cancer Statistics Review, 1975-2005. National Cancer Institute; Bethesda, MD: 2008. Available at: seer. cancer. gov/csr/1975-2001 2007.
6. Klint Å, Engholm G, Storm HH, Tryggvadóttir L, Gislum M, Hakulinen T and Bray F. Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010; 49: 578-607.
7. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, Rosenberg PS, Bray F and Gillison ML. Worldwide Trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 2013; 31: 4550-4559.
8. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000; 19: 1-5.
9. Moberg M, Gustavsson I and Gyllensten U. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol 2003; 41: 3221-3228.
10. Naucler P, Chen HC, Persson K, You SL, Hsieh CY, Sun CA, Dillner J and Chen CJ. Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study. J Gen Virol 2007; 88: 814-822.
11. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC and Lu C. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
12. Syrjänen K. Histological changes identical to those of condylomatous lesions found in esophageal squamous cell carcinomas. Arch Geschwulstforsch 1981; 52: 283-292.
13. Rietbergen MM, Leemans CR, Bloemena E, Heideman DA, Braakhuis BJ, Hesselink AT, Witte BI, Baatenburg de Jong RJ, Meijer CJ and Snijders PJ. Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer 2013; 132: 1565-1571.
14. El-Naggar AK and Westra WH. p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: A guide for interpretative relevance and consistency. Head Neck 2012; 34: 459-461.
15. Shi W, Kato H, Perez-Ordonez B, Pintilie M, Huang S, Hui A, O'Sullivan B, Waldron J, Cummings B and Kim J. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol 2009; 27: 6213-6221.
16. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A and Gillison ML. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Nati Cancer Inst 2008; 100: 261-269.
17. Reimers N, Kasper HU, Weissenborn SJ, Stützer H, Preuss SF, Hoffmann TK, Speel EJ, Dienes HP, Pfister HJ and Guntinas-Lichius O. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 2007; 120: 1731-1738.
18. Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, Sasaki C, Joe J, Camp RL and Rimm DL. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006; 24: 736-747.
19. Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J and Overgaard J. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol 2009; 27: 1992-1998.
20. Ragin CC and Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta-analysis. Int J Cancer 2007; 121: 1813-1820.
21. Edge SB and Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-1474.
22. Berumen J, Unger ER, Casas L and Figueroa P. Amplification of human papillomavirus types 16 and 18 in invasive cervical cancer. Hum Pathol 1995; 26: 676-681.
23. Gao Y, Hu N, Han X, Giffen C, Ding T, Goldstein A and Taylor P. Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China. BMC Cancer 2009; 9: 269.
24. Wen D, Shan B, Wang S, Zhang L, Wei L, Zhou W and Peng Q. A positive family history of esophageal/gastric cardia cancer with gastric cardia adenocarcinoma is associated with a younger age at onset and more likely with another synchronous esophageal/gastric cardia cancer in a Chinese high-risk area. Eur J Med Genet 2010; 53: 250-255.
25. Zheng S, Vuitton L, Sheyhidin I, Vuitton DA, Zhang Y and Lu X. Northwestern China: a place to learn more on oesophageal cancer. Part two: gene alterations and polymorphisms. Eur J Gastroenterol Hepatol 2011; 23: 1087-1099.
26. zur Hausen H. Papillomaviruses in the causation of human cancers-a brief historical account. Virology 2009; 384: 260-265.
27. Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D and Nawroz H. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996; 56: 3630-3633.
28. Parkin DM, Bray F, Ferlay J and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
29. Dahlgren L, Mellin H, Wangsa D, Heselmeyer-Haddad K, Bjornestal L, Lindholm J, Munck-Wikland E, Auer G, Ried T and Dalianis T. Comparative genomic hybridization analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papillomavirus-positive and -negative tumors. Int J Cancer 2003; 107: 244-249.
30. Kahla S, Kochbati L, Maalej M and Oueslati R. Situation of HPV16 E2 gene status during radiotherapy treatment of cervical carcinoma. Asian Pac J Cancer Prev 2014; 15: 2869-2873.
31. Schwartz SM, Daling JR, Madeleine MM, Doody DR, Fitzgibbons ED, Wipf GC, Carter JJ, Mao EJ, Huang S and Beckmann AM. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Nati Cancer Insti 1998; 90: 1626-1636.
32. Kong CS, Narasimhan B, Cao H, Kwok S, Erickson JP, Koong A, Pourmand N and Le QT. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2009; 74: 553-561.